Comparison of Voriconazole and Amphotericin B in Treating Patients With Aspergillosis

Completed · Phase 3

Conditions studied: Infection, Pulmonary Complications

In brief

RATIONALE: Antifungal therapy with voriconazole or amphotericin B may be an effective treatment for aspergillosis. It is not yet known whether voriconazole is more effective than amphotericin B in treating patients with aspergillosis. PURPOSE: Randomized phase III trial to compare the effectiveness of voriconazole with amphotericin B in treating patients with aspergillosis.

Key facts

Study ID
NCT00003031
Run by
European Organisation for Research and Treatment of Cancer - EORTC
People needed
212
Starts
1997-06-01
Last updated by the study team
2012-07-02

Who can join

Age: 12 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.